OKLAHOMA CITY, July 13, 2022 — The National Institutes of Health has awarded the Oklahoma Medical Research Foundation $3 million to continue the study of the anti-aging abilities of a diabetes drug.The five-year grant will allow OMRF physiologist Benjamin Miller, Ph.D., to continue his investigation of the ability of metformin,